Gene Therapy May Have Reversed Human Aging For First Time

Posted by K R on

The controversial process of reversing aging through gene therapy is no longer solely for mice, if–and it’s a big if–new data from biotech firm BioViva can be validated. The company claims that their 44-year-old CEO, Elizabeth Parrish of Seattle, has become the first human to be “successfully rejuvenated by gene therapy,” after two experimental procedures appear to have reversed 20 years of normal telomere shortening. BioViva explains:
In September 2015… Elizabeth Parrish received two of her own company’s experimental gene therapies: one to protect against loss of muscle mass with age, another to battle stem cell depletion responsible for diverse age-related diseases and infirmities.
The company’s intent was to demonstrate that these treatments–which Parrish, as Patient Zero, underwent in Colombia so as not to incur the wrath of the FDA–are fundamentally safe. But early data suggests that in the six months following the administration of the gene therapies Parrish’s telomeres lengthened from 6.71kb to 7.33kb, which would imply that her white blood cells became 20 years “younger” in that time. Read More: Mysterious Universe

Share this post



← Older Post Newer Post →


0 comments

Leave a comment